112 related articles for article (PubMed ID: 31560141)
1. CD44-Specific A6 Short Peptide Boosts Targetability and Anticancer Efficacy of Polymersomal Epirubicin to Orthotopic Human Multiple Myeloma.
Gu W; An J; Meng H; Yu N; Zhong Y; Meng F; Xu Y; Cornelissen JJLM; Zhong Z
Adv Mater; 2019 Nov; 31(46):e1904742. PubMed ID: 31560141
[TBL] [Abstract][Full Text] [Related]
2. A6 peptide activates CD44 adhesive activity, induces FAK and MEK phosphorylation, and inhibits the migration and metastasis of CD44-expressing cells.
Piotrowicz RS; Damaj BB; Hachicha M; Incardona F; Howell SB; Finlayson M
Mol Cancer Ther; 2011 Nov; 10(11):2072-82. PubMed ID: 21885863
[TBL] [Abstract][Full Text] [Related]
3. CD44-targeting hydrophobic phosphorylated gemcitabine prodrug nanotherapeutics augment lung cancer therapy.
Guo B; Wei J; Wang J; Sun Y; Yuan J; Zhong Z; Meng F
Acta Biomater; 2022 Jun; 145():200-209. PubMed ID: 35430336
[TBL] [Abstract][Full Text] [Related]
4. A6 peptide-tagged, ultra-small and reduction-sensitive polymersomal vincristine sulfate as a smart and specific treatment for CD44+ acute myeloid leukemia.
Gu W; Liu T; Fan D; Zhang J; Xia Y; Meng F; Xu Y; Cornelissen JJLM; Liu Z; Zhong Z
J Control Release; 2021 Jan; 329():706-716. PubMed ID: 33031878
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of HSP90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancer.
Jia L; Yang H; Liu Y; Zhou Y; Li G; Zhou Q; Xu Y; Huang Z; Ye F; Ye J; Liu A; Ji C
J Nanobiotechnology; 2024 Apr; 22(1):198. PubMed ID: 38649957
[TBL] [Abstract][Full Text] [Related]
6. A6 Peptide-Tagged Core-Disulfide-Cross-Linked Micelles for Targeted Delivery of Proteasome Inhibitor Carfilzomib to Multiple Myeloma In Vivo.
Zhang C; Wang X; Cheng R; Zhong Z
Biomacromolecules; 2020 Jun; 21(6):2049-2059. PubMed ID: 32338875
[TBL] [Abstract][Full Text] [Related]
7. HER2-Specific Reduction-Sensitive Immunopolymersomes with High Loading of Epirubicin for Targeted Treatment of Ovarian Tumor.
Ding L; Gu W; Zhang Y; Yue S; Sun H; Cornelissen JJLM; Zhong Z
Biomacromolecules; 2019 Oct; 20(10):3855-3863. PubMed ID: 31513391
[TBL] [Abstract][Full Text] [Related]
8. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo.
Wei Y; Gu X; Cheng L; Meng F; Storm G; Zhong Z
Acta Biomater; 2019 Jul; 92():196-204. PubMed ID: 31102765
[TBL] [Abstract][Full Text] [Related]
9. Improved anticancer efficacy of epirubicin by magnetic mesoporous silica nanoparticles: in vitro and in vivo studies.
Ansari L; Jaafari MR; Bastami TR; Malaekeh-Nikouei B
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):594-606. PubMed ID: 29688064
[TBL] [Abstract][Full Text] [Related]
10. EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo.
Fang Y; Yang W; Cheng L; Meng F; Zhang J; Zhong Z
Acta Biomater; 2017 Dec; 64():323-333. PubMed ID: 29030307
[TBL] [Abstract][Full Text] [Related]
11. CD44-targeted vesicles encapsulating granzyme B as artificial killer cells for potent inhibition of human multiple myeloma in mice.
Zhong Y; Meng F; Zhang W; Li B; van Hest JCM; Zhong Z
J Control Release; 2020 Apr; 320():421-430. PubMed ID: 32027936
[TBL] [Abstract][Full Text] [Related]
12. A novel FAPα-based Z-Gly-Pro epirubicin prodrug for improving tumor-targeting chemotherapy.
Wang J; Li Q; Li X; Yuan W; Huang S; Cai S; Xu J
Eur J Pharmacol; 2017 Nov; 815():166-172. PubMed ID: 28919026
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of epirubicin-loaded lipid microbubbles with conjugated anti-ABCG2 antibody combined with therapeutic ultrasound on multiple myeloma cancer stem cells.
Shi F; Yang F; He X; Zhang Y; Wu S; Li M; Zhang Y; Di W; Dou J; Gu N
J Drug Target; 2016; 24(1):34-46. PubMed ID: 26204324
[TBL] [Abstract][Full Text] [Related]
14. Folic acid Targeted Polymeric Micelles Based on Tocopherol Succinate- Pulluan as an Effective Carrier for Epirubicin: Preparation, Characterization and In-vitro Cytotoxicity Assessment.
Hassanzadeh F; Mehdifar M; Varshosaz J; Khodarahmi GA; Rostami M
Curr Drug Deliv; 2018 Feb; 15(2):235-246. PubMed ID: 28571542
[TBL] [Abstract][Full Text] [Related]
15. A urokinase-derived peptide (A6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasis.
Boyd DD; Kim SJ; Wang H; Jones TR; Gallick GE
Am J Pathol; 2003 Feb; 162(2):619-26. PubMed ID: 12547719
[TBL] [Abstract][Full Text] [Related]
16. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
[TBL] [Abstract][Full Text] [Related]
17. Polymer-drug conjugates for combination anticancer therapy: investigating the mechanism of action.
Pasut G; Greco F; Mero A; Mendichi R; Fante C; Green RJ; Veronese FM
J Med Chem; 2009 Oct; 52(20):6499-502. PubMed ID: 19764729
[TBL] [Abstract][Full Text] [Related]
18. Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo.
Taghdisi SM; Danesh NM; Ramezani M; Lavaee P; Jalalian SH; Robati RY; Abnous K
Eur J Pharm Biopharm; 2016 May; 102():152-8. PubMed ID: 26987703
[TBL] [Abstract][Full Text] [Related]
19. Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells in vitro and in vivo.
Yazdian-Robati R; Arab A; Ramezani M; Rafatpanah H; Bahreyni A; Nabavinia MS; Abnous K; Taghdisi SM
Drug Dev Ind Pharm; 2019 Apr; 45(4):603-610. PubMed ID: 30633594
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of tumour microenvironment response multistage nanoparticles for epirubicin delivery and deep tumour penetration.
Dai J; Han S; Ju F; Han M; Xu L; Zhang R; Sun Y
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):860-873. PubMed ID: 29771149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
